A Case of Metastatic Urothelial Carcinoma Treated with Pemetrexed as Third-Line Chemotherapy with Discussion and Literature Review

Publisher： Karger

E-ISSN： 1662-6575|8|3|530-535

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.8, Iss.3, 2015-11, pp. : 530-535

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Third-Line Chemotherapy with Irinotecan plus 5-Fluorouracil in Caucasian Metastatic Gastric Cancer Patients

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 311-316

Karger

Access to resources Recommend Favorite

S-1 Monotherapy as Second- or Third-Line Chemotherapy for Unresectable and Recurrent Esophageal Squamous Cell Carcinoma

By  

Oncology, Vol. 84, Iss. 5, 2013-04 ,pp. : 305-310

Karger

Access to resources Recommend Favorite

Relationship between 6‐ and 9‐month progression‐free survival and overall survival in patients with metastatic urothelial cancer treated with first‐line cisplatin‐based chemotherapy

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 3020-3026

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study)

By  

Oncology, Vol. 91, Iss. 1, 2016-05 ,pp. : 24-30

Karger

Access to resources Recommend Favorite

Successful Management of Metastatic Urothelial Carcinoma with Gemcitabine and Paclitaxel Chemotherapy in a Hemodialysis Patient

By  

Urologia Internationalis, Vol. 87, Iss. 2, 2011-06 ,pp. : 245-247

Karger

Access to resources Recommend Favorite